“…Morris, Wolfson Centre for Inherited Neuromuscular Disease), 26 NCL-DYSB recognizing amino acids 321 to 494 (Novocastra Laboratories, Newcastle, UK), NCL-DYS1 recognizing amino acids 1181 to 1388 (Novocastra), MANDYS8 recognizing amino acids 1431 to 1505 (Sigma-Aldrich, St Louis, Mo), F22.9C5 recognizing amino acids 1840 to 2266 (Alexis, Lausen, Switzerland), or NCL-DYS2 recognizing amino acids 3669 to 3685 (Novocastra); mouse monoclonal antibodies against -dystroglycan (NCL-b-DG, Novocastra), -sarcoglycan (NCL-b-SG, Novocastra), ␥-sarcoglycan (NCL-g-SG, Novocastra), or ␦-sarcoglycan (DSG-1) 27 ; rabbit polyclonal antibodies against utrophin (UT-2), 28 ␣-sarcoglycan (␣-SG2), 29 or -calpain (anticalpain 1 large subunit domain IV; Sigma-Aldrich). The primary antibodies were labeled with fluorescein-conjugated goat anti-mouse or anti-rabbit immunoglobulin G (Molecular Probes, Eugene, Ore), and signals were recorded photographically with a confocal laser scanning microscope (TCSSP, Leica).…”